UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 83

Sortiert nach

Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse

Journal of thrombosis and haemostasis, 2013-03, Vol.11 (3), p.481-490

2013

Volltextzugriff (PDF)

A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom

Journal of thrombosis and haemostasis, 2012-09, Vol.10 (9), p.1792-1801

2012

Volltextzugriff (PDF)

ADAMTS‐13 assays in thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2010-04, Vol.8 (4), p.631-640

2010

Volltextzugriff (PDF)

The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients

Thrombosis research, 2012-07, Vol.130 (1), p.110-114

2012

Volltextzugriff (PDF)

Persistent high factor VIII activity leading to increased thrombin generation – A prospective cohort study

Thrombosis research, 2012-04, Vol.129 (4), p.447-452

2012

Volltextzugriff (PDF)

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Thrombosis research, 2015-02, Vol.135 (2), p.388-393

2015

Volltextzugriff (PDF)

Prevalence of the ADAMTS‐13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2008-02, Vol.6 (2), p.331-338

2008

Volltextzugriff (PDF)

ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate

International journal of laboratory hematology, 2017-10, Vol.39 (5), p.448-457

2017

Volltextzugriff (PDF)

Mean platelet volume: a quick, easy determinant of thrombotic risk?

Journal of thrombosis and haemostasis, 2010-01, Vol.8 (1), p.146-147

2010

Volltextzugriff (PDF)

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2015-07, Vol.13 (7), p.1264-1273

2015

Volltextzugriff (PDF)

29 Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C

Thrombosis research, 2007, Vol.119, p.S104-S105

2007

Volltextzugriff (PDF)

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Journal of thrombosis and haemostasis, 2016-11, Vol.14 (11), p.2177-2186

2016

Volltextzugriff (PDF)

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Journal of thrombosis and haemostasis, 2014-11, Vol.12 (11), p.1801-1809

2014

Volltextzugriff (PDF)

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

Journal of thrombosis and haemostasis, 2010-06, Vol.8 (6), p.1201-1208

2010

Volltextzugriff (PDF)

Factor XIII – an under diagnosed deficiency – are we using the right assays?

Journal of thrombosis and haemostasis, 2010-11, Vol.8 (11), p.2478-2482

2010

Volltextzugriff (PDF)

Haemostasis

Surgery (Oxford), 2007-06, Vol.25 (6), p.241-244

2007

Volltextzugriff (PDF)

Pros and cons of thrombophilia testing: cons

Journal of thrombosis and haemostasis, 2003-03, Vol.1 (3), p.412-413

Machin, S. J.

2003

Volltextzugriff (PDF)

The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies

Journal of thrombosis and haemostasis, 2004-07, Vol.2 (7), p.1077-1081

2004

Volltextzugriff (PDF)

Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis

Thrombosis and haemostasis, 2002-05, Vol.87 (5), p.802

2002

Volltextzugriff (PDF)

Hemostatic-endothelial interactions: A potential anticoagulant role of the endothelium in the pulmonary circulation during cardiac surgery

Journal of Cardiothoracic and Vascular Anesthesia, 1997-05, Vol.11 (3), p.329-336

1997

Volltextzugriff (PDF)

Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C

Journal of thrombosis and haemostasis, 2006-12, Vol.4 (12), p.2724-2726

2006

Volltextzugriff (PDF)

The most accurate platelet count on the Sysmex XE-2100. Optical or impedance?

Clinical and laboratory haematology, 2004-04, Vol.26 (2), p.157-158

2004

Volltextzugriff (PDF)

A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS

Journal of thrombosis and haemostasis, 2007-07, Vol.5, p.P-T-089-P-T-089

2007

Volltextzugriff (PDF)

Trigger factors for prophylactic platelet transfusion

Blood reviews, 1998-12, Vol.12 (4), p.234-238

1998

Volltextzugriff (PDF)

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

The Lancet (British edition), 1990-10, Vol.336 (8722), p.1022-1025

1990

Volltextzugriff (PDF)

1 – 25 von 83

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(80)
Mit Volltextzugriff
(70)

Publikationsform

Artikel
(82)
Dissertationen
(1)

Sprache

Englisch
(83)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Thrombosis And Haemostasis
(14)
The Lancet
(14)
Thrombosis Research
(13)
Clinical And Laboratory Haematology
(5)
Vox Sanguinis
(4)
The Journal Of Hospital Infection
(3)
Acta Haematologica
(2)
Anaesthesia
(2)
Blood Reviews
(2)
Fibrinolysis
(2)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Rituximab for thrombotic thrombocytopenic purpura: benefit of early administration during acute episodes and use of prophylaxis to prevent relapse

A phenotype–genotype correlation of ADAMTS13 mutations in congenital thrombotic thrombocytopenic purpura patients treated in the United Kingdom

ADAMTS‐13 assays in thrombotic thrombocytopenic purpura

The clinical significance of differences between point-of-care and laboratory INR methods in over-anticoagulated patients

Persistent high factor VIII activity leading to increased thrombin generation – A prospective cohort study

Rivaroxaban and warfarin achieve effective anticoagulation, as assessed by inhibition of TG and in-vivo markers of coagulation activation, in patients with venous thromboembolism

Prevalence of the ADAMTS‐13 missense mutation R1060W in late onset adult thrombotic thrombocytopenic purpura

ICSH recommendations for modified and alternate methods measuring the erythrocyte sedimentation rate

Mean platelet volume: a quick, easy determinant of thrombotic risk?

Interactions between rivaroxaban and antiphospholipid antibodies in thrombotic antiphospholipid syndrome

29 Pregnancy morbidity, tissue factor pathway inhibitor deficiency and resistance to activated protein C

Rivaroxaban limits complement activation compared with warfarin in antiphospholipid syndrome patients with venous thromboembolism

Anti‐protein C antibodies are associated with resistance to endogenous protein C activation and a severe thrombotic phenotype in antiphospholipid syndrome

Rituximab pharmacokinetics during the management of acute idiopathic thrombotic thrombocytopenic purpura

Factor XIII – an under diagnosed deficiency – are we using the right assays?

Haemostasis

Pros and cons of thrombophilia testing: cons

The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies

Patients with essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis

Hemostatic-endothelial interactions: A potential anticoagulant role of the endothelium in the pulmonary circulation during cardiac surgery

Pregnancy loss, tissue factor pathway inhibitor deficiency and resistance to activated protein C

The most accurate platelet count on the Sysmex XE-2100. Optical or impedance?

A COMPARATIVE EVALUATION OF THE CS-2000I COAGULATION ANALYSER USING CLOTTING, AMIDOLYTIC AND IMMUNO-TURBIDOMETRIC ASSAYS

Trigger factors for prophylactic platelet transfusion

Demonstration of viraemia patterns in haemophiliacs treated with hepatitis-C-virus-contaminated factor VIII concentrates

Suchergebnisse filtern